Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States

BACKGROUND AND OBJECTIVE: Significant clinical burden is associated with higher-risk myelodysplastic syndromes (HR-MDS); however, the economic burden has not been fully examined. We examined cost of care and healthcare utilization (HCU) in HR-MDS patients engaged in routine care in the United States...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Jill A., Galaznik, Aaron, Blazer, Marlo, Shih, Huai-Che, Farrelly, Eileen, Ogbonnaya, Augustina, Eaddy, Michael, Fram, Robert J., Faller, Douglas V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533351/
https://www.ncbi.nlm.nih.gov/pubmed/30324565
http://dx.doi.org/10.1007/s41669-018-0100-5

Ejemplares similares

Ejemplares similares